Abstract:Background With the decline of the use of ketamine, one of the common drugs of abuse in Hong Kong, detection of ketamine-related analogues in local laboratories has been encountered. Aim: A brief account of the occurrence of fluorodeschloroketamine (FDCK) in forensic cases is reported through a retrospective study of all drug seizures and driving under the influence of drugs (DUID) cases since its first appearance. Methods: Identification of FDCK in drug seizures was achieved through gas chromatography – mass spectrometry (GC-MS) and/or liquid chromatography – diode array detection (LC-DAD) methods while its quantification was performed using gas chromatography – flame ionization detection (GC-FID). For the analysis of blood samples in DUID cases, identification and quantification were performed using LC-MS/MS by monitoring the respective transitions of FDCK and fluorodeschloronorketamine (FDCNK) using ketamine-d 4 and norketamine-d 4 respectively as internal standards. Results: Since its first submission in November 2018, a total of 74 drug seizure cases (151 items) and 6 drug driving cases were encountered till December 2019. Drug seizures found with FDCK were physically similar to those of ketamine seizures. The majority of items were detected with FDCK only (103 items, ~67%) or as a mixture of FDCK with ketamine (42 items, ~28%). The drug purity detected with either FDCK only or FDCK mixed with ketamine was high which was similar to those purity found in ketamine seizures. The blood drug concentrations of FDCK of the 6 drug driving cases were in the range of <0.002 to 1.1 μg/mL and other psychoactive drug(s)/metabolite(s) were also identified. Except for one case where the analysis of the metabolite, fluorodeschloronorketamine (FDCNK), was not conducted due to insufficient sample, the FDCK (FDCNK) concentrations in blood found in the 6 cases were <0.002 (0.005), 0.002 (0.002), 0.002 (0.003), 0.02 (0.035), 0.87 (0.44) and 1.1 (not determined) μg/mL. Conclusions: With the drug seizures found with FDCK resembled in physical appearance with ketamine seizures, users might likely misuse it as ketamine. Though complicated by other drugs found, it is speculated that the two cases with higher concentration of FDCK found in blood (1.1 and 0.87 μg/mL) might have contributed to the impairment observed.

Wastewater-based Monitoring of 2-Fluoro-deschloroketamine Abuse from 2019 to 2021 in a Southern Chinese Province.

Fluorodeschloroketamine found as a street drug in drug seizures and drug driving cases in Hong Kong

Methamphetamine and ketamine use in major Chinese cities, a nationwide reconnaissance through sewage-based epidemiology

Nationwide assessment of illicit drug consumption patterns in South Korea using wastewater-based epidemiology during the COVID-19 pandemic (2020-2022)

2-Fluorodeschloroketamine consumption: About two deaths and a case of self-mutilation

Characterization of extensive 2-fluorodeschloroketamine metabolism in pooled human liver microsomes, urine and hair from an addicted patient using high-resolution accurate mass spectrometry

In vitro and in vivo metabolic study of three new psychoactive β-keto-arylcyclohexylamines

Estimation of the Psychoactive Substances Consumption Within 12 Wastewater Treatment Plants Service Areas in a Certain City of Guangxi, China Applying Wastewater-Based Epidemiology.

Assessing patterns of illicit drug use in a Chinese city by analyzing daily wastewater samples over a one-year period

EPIDEMIOLOGICAL SURVEY OF KETAMINE IN CHINA

Evaluation of the Occurrence of Psychotropic Drugs in Urban Sewage and the Abuse During the COVID-19 Epidemic Period in a City of Guangdong

Monitoring of ketamine-based emerging contaminants in wastewater: a direct-injection method and fragmentation pathway study

Ketamine and International Regulations

Illegal use patterns, side effects, and analytical methods of ketamine

A Revised Excretion Factor for Estimating Ketamine Consumption by Wastewater-Based Epidemiology – Utilising Wastewater and Seizure Data

Monitoring Consumption of Common Illicit Drugs in Kuala Lumpur, Malaysia, by Wastewater-Cased Epidemiology

Wastewater-based epidemiology to monitor 68 NPS/conventional drug use in Taipei metropolitan area in Taiwan during and after COVID-19 pandemic

Application of Wastewater-Based Epidemiology in China From Wastewater Monitoring to Drug Control Efforts

A combined toxicokinetic and metabolic approach to investigate deschloro-N-ethylketamine exposure in a multidrug user

Occurrence of New Psychoactive Substances in Wastewater of Major Chinese Cities

Tracing Methamphetamine and Amphetamine Sources in Wastewater and Receiving Waters Via Concentration and Enantiomeric Profiling.